Gara Jalqabaatti › Sindroomii Sjogren › Illinois
Qorannoo klinikaalii Sindroomii Sjogren Illinois keessatti
Qorannoo 5 Sindroomii Sjogren f Illinois keessatti hirmaatuu jiru.
Magaalota Illinois keessatti
Takkalaa qorannoo (Ingiliffa)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Willow Rheumatology Wellness, Willowbrook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07621809A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Chicago Clinical Research Inst, Chicago
- Willow Rheumatology Wellness, Willowbrook
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07737743Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Chicago Clinical Research Institute Inc, Chicago
- Clinical Investigation Specialist, Schaumburg
- Willow Rheumatology & Wellness, Willowbrook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07404865AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Willowbrook, Willowbrook
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06991114The Myelin Disorders Biorepository Project
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 23-Onk-2025 · NCT03047369Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.